TMO Thermo Fisher Scientific Inc.

688.75USD-0.58%Mkt Cap: 255.19B USDP/E: 36.33

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally. It operates through four segments: Life Scien…

Insiders, last 90 daysNet sellers
Institutional holders20 on file

Key Statistics

Company
Market Cap255.19B USD
Enterprise Value292.11B USD
Revenue (TTM)47.35B USD
Gross Profit18.24B USD
Net Income (TTM)6.70B USD
Revenue/Share127.37 USD
Last Price688.75 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees125.0K
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)36.33
P/E (Forward)24.79
PEG2.01
EV/EBITDA24.08
EV/Revenue6.17
P/S5.39
P/B4.66
EPS (TTM)18.72 USD
EPS (Forward)27.78 USD
52W Range
435.2787% of range727.56
52W High727.56 USD
52W Low435.27 USD
Profitability
Gross Margin40.93%
Oper. Margin19.06%
EBITDA Margin25.62%
Profit Margin15.05%
ROE12.55%
ROA6.08%
ROIC9.06%
ROCE8.52%
Growth
Revenue Growth9.10%
Earnings Growth8.70%
Cash Flow & Leverage
Operating CF7.82B USD
CapEx (TTM)1.52B USD
FCF Margin13.60%
FCF Yield2.52%
Net Debt35.31B USD
Net Debt/EBITDA2.91
Net Debt/FCF5.48
Balance Sheet
Debt/Equity0.74
Current Ratio1.81
Quick Ratio1.23
Book Value/Sh147.80 USD
Cash/Share16.36 USD
Dividends
Fwd Div Rate1.88 USD
Trail. Div Rate1.84 USD
Div. Yield0.27%
5Y Avg Yield0.25%
Payout Ratio9.70%
Ex-Div DateDec 15, 2026
Pay DateJan 15, 2027
Splits
Last Split3:2
Split DateJun 6, 1996
Analyst Consensus
Rating1.4 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)756.52 USD
Upside (mean)+9.8%
Target Range590.00 USD – 830.00 USD
590.00+9.8% to mean830.00
# Analysts25
Ownership
Shares Out.370.52M
Float369.62M
Insiders0.22%
Institutions95.97%
Short Interest
Short Ratio2.0d
Short % Float1.29%
Short % Out.1.29%
Shares Short4.78M
Short (prev mo.)5.41M
Technical
SMA 50672.17 (+2.5%)
SMA 200555.94 (+23.9%)
Beta0.84
S&P 52W Chg12.08%
Avg Vol (30d)2.17M
Avg Vol (10d)2.01M
Technical Indicators
RSI (14)49.6
MACD5.4105
MACD Signal8.8092
MACD Hist.-3.3987
BB Upper723.33 USD
BB Middle696.89 USD
BB Lower670.44 USD
BB Width7.59%
ATR (14)18.92 USD
Vol Ratio (20d)0.95x

About Thermo Fisher Scientific (NYSE: TMO)

›

Thermo Fisher Scientific (NYSE: TMO) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Diagnostics & Research industry, part of the Healthcare sector, and reports about 125,000 employees.

The shares were at 688.75 USD on 19 November 2026, up 19.2% over 52 weeks. Its 52-week range is 435.27 USD to 727.56 USD: the price is 5.3% below the high and 58.2% above the low.

At a market capitalisation of 255.19B USD, it trades at 36.3 times trailing earnings and 24.8 times forward earnings. The median trailing P/E of its 18 largest Diagnostics & Research peers is 34.9, so TMO is valued in line with them. It pays a dividend yielding 0.27% (it pays out 10% of its earnings), against a median of 0.77% among the dividend payers in that peer group.

Thermo Fisher Scientific reports return on equity of 12.6%, an operating margin of 19.1% and revenue up 9.1% year over year.

Its debt exceeds its cash by 35.31B USD, a debt-to-equity ratio of 0.74. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 25 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 756.52 USD is 9.8% above the current price. The next earnings report is expected on 28 January 2027.